FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-125385.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Supplemental Table
Right arrow Buy
Right arrow All Versions of this Article:
fj.08-125385v1
fj.08-125385v2
fj.08-125385v3
23/5/1470    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yasuda, D.
Right arrow Articles by Nakamura, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yasuda, D.
Right arrow Articles by Nakamura, M.
(The FASEB Journal. 2009;23:1470-1481.)
© 2009 FASEB

Helix 8 of leukotriene B4 type-2 receptor is required for the folding to pass the quality control in the endoplasmic reticulum

Daisuke Yasuda*, Toshiaki Okuno{dagger}, Takehiko Yokomizo{dagger}, Tetsuya Hori{ddagger}, Nobuaki Hirota*, Tomomi Hashidate*, Masashi Miyano{ddagger}, Takao Shimizu* and Motonao Nakamura*,1

* Department of Biochemistry and Molecular Biology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan;

{dagger} Department of Medical Biochemistry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; and

{ddagger} Structural Biophysics Laboratory, RIKEN Harima Institute at Spring-8, Hyogo, Japan

1 Correspondence: Department of Biochemistry and Molecular Biology, Faculty of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. E-mail: moto-nakamura{at}umin.net

Many G protein-coupled receptors (GPCRs) possess a putative cytoplasmic helical domain, termed helix 8 (H8), at the proximal region of the C-terminal tail. However, the significance of this domain is not fully understood. Here, we demonstrate the requirement of H8 for the proper folding of GPCRs for passage through the quality control in the endoplasmic reticulum (ER). In the human leukotriene B4 type-2 receptor (hBLT2), lack of H8 led to an accumulation of the receptor (hBLT2/{Delta}H8) in the ER. Similar results were obtained in two representative human GPCRs, dopamine type-1 and lysophosphatidic acid type-2 receptors, which were engineered to lack H8. Treatment with the several ligands, which act as pharmacological chaperones, facilitated the surface expression of hBLT2/{Delta}H8. The surface-trafficked hBLT2/{Delta}H8 exhibited an agonist-evoked increase in Ca2+, demonstrating that H8 is not critical for ligand binding and activation of coupled G proteins. Thus, these results suggest that the H8 region of hBLT2 plays an important role in transport-competent receptor folding.—Yasuda, D., Okuno, T., Yokomizo, T., Hori, T., Hirota, N., Hashidate, T., Miyano, M., Shimizu, T., Nakamura, M. Helix 8 of leukotriene B4 type-2 receptor is required for the folding to pass the quality control in the endoplasmic reticulum.


Key Words: G protein-coupled receptor • trafficking • pharmacological chaperone • ERAD • 12-HHT




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. Hirota, D. Yasuda, T. Hashidate, T. Yamamoto, S. Yamaguchi, T. Nagamune, T. Nagase, T. Shimizu, and M. Nakamura
Amino Acid Residues Critical for Endoplasmic Reticulum Export and Trafficking of Platelet-activating Factor Receptor
J. Biol. Chem., February 19, 2010; 285(8): 5931 - 5940.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. U. Gehret, B. W. Jones, P. N. Tran, L. B. Cook, E. K. Greuber, and P. M. Hinkle
Role of Helix 8 of the Thyrotropin-Releasing Hormone Receptor in Phosphorylation by G Protein-Coupled Receptor Kinase
Mol. Pharmacol., February 1, 2010; 77(2): 288 - 297.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.